{"id":"NCT01341782","sponsor":"AbbVie (prior sponsor, Abbott)","briefTitle":"Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism","officialTitle":"Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05","primaryCompletion":"2012-04","completion":"2012-04","firstPosted":"2011-04-26","resultsPosted":"2013-06-06","lastUpdate":"2013-06-06"},"enrollment":255,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Secondary Hyperparathyroidism","Hemodialysis"],"interventions":[{"type":"DRUG","name":"paricalcitol","otherNames":["ABT-358","Zemplar"]},{"type":"DRUG","name":"maxacalcitol","otherNames":["oxarol"]},{"type":"DRUG","name":"paricalcitol placebo","otherNames":[]},{"type":"DRUG","name":"maxacalcitol placebo","otherNames":[]}],"arms":[{"label":"Paricalcitol","type":"EXPERIMENTAL"},{"label":"Maxacalcitol","type":"ACTIVE_COMPARATOR"}],"summary":"This study is a comparison of the efficacy and safety of paricalcitol injection with maxacalcitol injection in adult Japanese chronic kidney disease patients receiving hemodialysis with secondary hyperparathyroidism. The main objective of this study is to demonstrate the efficacy of paricalcitol injection in reducing levels of parathyroid hormone without clinically significant hypercalcemia, compared to maxacalcitol injection.","primaryOutcome":{"measure":"Percentage of Participants With Target Intact Parathyroid Hormone (iPTH) and Without Hypercalcemia","timeFrame":"iPTH measured during the last three weeks of treatment (Weeks 11, 12, and 13). Calcium measured throughout the study (Weeks 1-13).","effectByArm":[{"arm":"Paricalcitol","deltaMin":27.7,"sd":null},{"arm":"Maxacalcitol","deltaMin":30.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":45,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":127},"commonTop":["Hypercalcaemia","Nasopharyngitis","Hypertension","Hyperphosphataemia","Procedural hypotension"]}}